Rytary NDC 64896-661

NDC codes

FDA NDC Directory

Product NDC (as listed)64896-661Labeler and product segments. Claims need a package NDC.

Product NDC at billing width64896-0661Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package
64896-661-01	64896066101	100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (64896-661-01)Marketed from Jan 12, 2015
64896-661-09	64896066109	25 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (64896-661-09)Marketed from Jan 12, 2015
64896-661-43	64896066143	240 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (64896-661-43)Marketed from Jan 12, 2015
64896-661-99	64896066199	100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (64896-661-99)Marketed from Jan 12, 2015

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Rytary
Generic name (nonproprietary): carbidopa and levodopa
Active ingredients: Levodopa — 95 mg/1Carbidopa hydrate — 23.75 mg/1
Dosage form: Capsule, Extended release
Route: Oral
Labeler: Amneal Pharmaceuticals LLC
Product type: Prescription drug
Marketing category: NDA — New Drug ApplicationApplication NDA 203312
Marketing start: Jan 12, 2015
Listing expires: Dec 31, 2027
Other FDA classes: Aromatic (Chemical structure)
Identifiers: Product ID 64896-661_ef3fe5ab-c753-409b-a5f3-b55e3eefd070SPL ID ef3fe5ab-c753-409b-a5f3-b55e3eefd070SPL set ID 6c1f7cd4-de56-45c1-a734-5e77b4aeb6f7RxCUI 1600773, 1600774, 1600775, 1600776, 1600914, 1600915, 1600916, 1600917UNII 46627O600J, MNX7R8C5VOUPC 0364896663016, 0364896664013, 0364896662019, 0364896661012
Pharmacologic class: Aromatic Amino Acid

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N464896066101 followed by a unit qualifier and the quantity

Package 64896-0661-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Mar 26, 2026.

Indications (excerpt from the label)

RYTARY is indicated for the treatment of Parkinson's disease, post-encephalitic parkinsonism, and parkinsonism that may follow carbon monoxide intoxication or manganese intoxication. RYTARY is a combination of carbidopa (an aromatic amino acid decarboxylation inhibitor) and levodopa (an aromatic amino acid) indicated for the treatment of Parkinson's disease, post-encephalitic parkinsonism, and parkinsonism that may follow carbon monoxide intoxication or manganese intoxication. ( 1 )

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under NDA 203312

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under NDA 203312
Product	Strength	Form · route	Labeler	Product NDC
Rytarycarbidopa and levodopa	Levodopa 195 mg/1; Carbidopa hydrate 48.75 mg/1	Capsule, Extended releaseOral	Amneal Pharmaceuticals LLC	64896-663
Rytarycarbidopa and levodopa	Levodopa 245 mg/1; Carbidopa hydrate 61.25 mg/1	Capsule, Extended releaseOral	Amneal Pharmaceuticals LLC	64896-664
Rytarycarbidopa and levodopa	Levodopa 145 mg/1; Carbidopa hydrate 36.25 mg/1	Capsule, Extended releaseOral	Amneal Pharmaceuticals LLC	64896-662
Carbidopa and Levodopa	Carbidopa 61.25 mg/1; Levodopa 245 mg/1	Capsule, Extended releaseOral	Zydus Pharmaceuticals USA Inc.	70710-2142
Carbidopa and Levodopa	Carbidopa 23.75 mg/1; Levodopa 95 mg/1	Capsule, Extended releaseOral	Zydus Pharmaceuticals USA Inc.	70710-2139
Carbidopa and Levodopa	Carbidopa 36.25 mg/1; Levodopa 145 mg/1	Capsule, Extended releaseOral	Zydus Pharmaceuticals USA Inc.	70710-2140
Carbidopa and Levodopa	Carbidopa 48.75 mg/1; Levodopa 195 mg/1	Capsule, Extended releaseOral	Zydus Pharmaceuticals USA Inc.	70710-2141
Carbidopa and Levodopa	Carbidopa 61.25 mg/1; Levodopa 245 mg/1	Capsule, Extended releaseOral	REMEDYREPACK INC.	70518-4610
Carbidopa and Levodopa	Carbidopa 23.75 mg/1; Levodopa 95 mg/1	Capsule, Extended releaseOral	REMEDYREPACK INC.	70518-4618
Carbidopa and Levodopa	Carbidopa 48.75 mg/1; Levodopa 195 mg/1	Capsule, Extended releaseOral	REMEDYREPACK INC.	70518-4621
Carbidopa and Levodopa	Carbidopa 36.25 mg/1; Levodopa 145 mg/1	Capsule, Extended releaseOral	REMEDYREPACK INC.	70518-4630